House of Commons Science and Technology Committee, November 2018
Selective non-publication of the results of research distorts the published evidence base and is a threat to research integrity. In the case of clinical trials, non-publication of results means that information on the efficacy of new drugs or other medical interventions cannot be used. Falling short on ‘clinical trials transparency’ in this way presents risks to human health, contributes to research wastage and means that clinical decisions are made without access to all the available evidence.
A range of UK and EU rules and guidelines are now in force to improve clinical trials transparency, in terms of tackling non-registration, non-reporting and mis-reporting. However, despite these rules, around half of clinical trials are currently left unreported, clinical trial registration is not yet universal in the UK, and reported outcomes do not always align with the original study proposal.
Click here to view the full report.
Category: Research
Priorities for Adult Social Work Research: Results from the James Lind Alliance Priority Setting Partnership for adult social work
Department of Health and Social Care, November 2018
This report sets out the top ten priorities for adult social work research. It aims to help make sure future research answers the questions that are important to social workers and those who are in contact with them. The priorities cover a broad range of themes and issues for adult social workers. These will help to improve understanding of the social work approaches and interventions that work and why, and help to achieve the best outcomes for people and their carers.
Click here to view the report.
LCFT Research Bulletin – October 2018
Lancashire Care, October 2018
Please click here to view the latest Lancashire Care Research bulletin to see research and journal articles produced by staff in the Trust.
World Alzheimer Report 2018: The State Of The Art Of Dementia Research: New Frontiers
Alzheimer’s Disease International, September 2018
Alzheimer’s Disease International report that looks at a broad cross section of research areas including basic science; diagnosis; drug discovery; risk reduction and epidemiology. With the continued absence of a disease modifying treatment, the report also features progress, innovation and developments in care research. It highlights an urgent need for increased and sustainable funding for dementia research.
Click here to view the full report.